ArticleCureus2024
Long-Term Effects of Fertility Treatments on Maternal Health.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The long-term health effects of assisted reproductive technologies, including in vitro fertilization (IVF) and hormonal therapies, remain poorly understood. This highlights the need to investigate potential chronic conditions that may arise following treatment. Objective The objective of this study was to investigate the long-term effects of fertility treatments on maternal health, with a focus on the incidence of chronic conditions and overall health outcomes in women who have undergone such treatments. Methodology This cross-sectional study included 180 women, aged 20-45, who had received fertility treatments and successfully delivered a live child. The research was conducted at Rehman Medical Institute and Hayatabad Medical Complex in Peshawar, Pakistan, from January to December 2023. Data were collected through medical record reviews and structured interviews to assess long-term health outcomes, including cancer, metabolic disorders, and cardiovascular diseases. Descriptive statistics and logistic regression were applied using IBM SPSS Statistics for Windows, Version 25.0 (Released 2017; IBM Corp., Armonk, NY, USA), with a significance threshold set at p < 0.05. Results The study included 180 participants with an average age of 34.5 years. Among them, 73 (40.56%) underwent hormone therapy, 81 (45.00%) used IVF, and 26 (14.44%) used intracytoplasmic sperm injection. All participants delivered live births, with 21 (11.67%) experiencing premature deliveries and 33 (18.33%) having multiple pregnancies. Key findings showed that nine (5.00%) developed cancer, 31 (17.22%) had metabolic disorders, and 24 (13.33%) developed cardiovascular disease. Overall, 146 (81.11%) participants reported excellent long-term health, while 34 (18.89%) had new diagnoses, including 12 (6.67%) with cardiovascular disease, 18 (10.00%) with metabolic disorders, and four (2.22%) with cancer. Additionally, 36 (20.00%) had preeclampsia, 21 (12.00%) experienced OHSS, and 12 (7.00%) developed gestational diabetes. Conclusions Despite most participants reporting excellent overall health, the study underscores the need for ongoing monitoring and management, as it reveals significant long-term health risks associated with fertility treatments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.